statistiche ricercatore

Continente	#
AS - Asia	579
NA - Nord America	425
EU - Europa	388
SA - Sud America	58
AF - Africa	4
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.455

Nazione	#
US - Stati Uniti d'America	405
SG - Singapore	217
IT - Italia	146
CN - Cina	142
RU - Federazione Russa	129
VN - Vietnam	109
BR - Brasile	45
HK - Hong Kong	42
DE - Germania	30
FR - Francia	16
FI - Finlandia	15
CA - Canada	14
IN - India	14
JP - Giappone	12
KR - Corea	12
GB - Regno Unito	10
NL - Olanda	10
BD - Bangladesh	7
BE - Belgio	5
AR - Argentina	4
ES - Italia	4
PL - Polonia	4
AL - Albania	3
CI - Costa d'Avorio	3
ID - Indonesia	3
IE - Irlanda	3
LT - Lituania	3
MX - Messico	3
PH - Filippine	3
PY - Paraguay	3
TH - Thailandia	3
CZ - Repubblica Ceca	2
IQ - Iraq	2
MN - Mongolia	2
PK - Pakistan	2
RS - Serbia	2
UA - Ucraina	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
BO - Bolivia	1
BS - Bahamas	1
CH - Svizzera	1
CL - Cile	1
CR - Costa Rica	1
CY - Cipro	1
DZ - Algeria	1
IL - Israele	1
IS - Islanda	1
JM - Giamaica	1
JO - Giordania	1
LV - Lettonia	1
NP - Nepal	1
PE - Perù	1
PS - Palestinian Territory	1
SE - Svezia	1
TR - Turchia	1
TW - Taiwan	1
UY - Uruguay	1
UZ - Uzbekistan	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.455

Nome	#
Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma Archetype	206
Impaired Seroconversion After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine in Patients With Thymic Epithelial Tumors	198
The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer	185
Extraskeletal Ewing's sarcoma of the mediastinum: Case report	156
DLL3 as a potential diagnostic and therapeutic target in neuroendocrine neoplasms: A narrative review	136
Exploring the interplay between Kaposi's sarcoma and SARS‐CoV‐2 infection: A case series and systematic review	134
Efficacy of PARP inhibitors in advanced high-grade serous ovarian cancer according to BRCA domain mutations and mutation type	130
Warming-up the immune cell engagers (ICEs) era in breast cancer: state of the art and future directions	128
The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): an Italian Delphi consensus report	88
Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic Intervention	59
Insights on the association of anthropometric and metabolic variables with tumor features and genomic risk in luminal early breast cancer: Results of a multicentric prospective study	51
Impact of relative dose intensity of first-line platinum-based chemotherapy in patients with thymic epithelial tumors: a retrospective study	3
Totale	1.474

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	13	0	0	0	0	0	0	0	0	0	9	1	3
2023/2024	90	6	11	11	12	2	4	2	8	1	3	11	19
2024/2025	388	4	8	1	18	19	13	50	25	15	54	144	37
2025/2026	983	78	92	87	66	140	77	176	50	98	68	41	10
Totale													1.474